Generic Drugs and Price Fixing

Teva Pharmaceuticals along with several other manufacturers are at the center of a lawsuit filed by Connecticut’s State Attorney General and the Attorney General of 44 additional states offices accusing the pharmaceutical companies of unlawfully inflating their drugs’ prices. This complaint was filed on May 10, 2019 against the top names in the pharmaceutical industry: Teva Pharmaceuticals, Mylan, Sandoz, Lupin, Greenstone, Actavis, Par, Taro, Zydus, Glenamark, Lannett, Amneal and Dr. Reddy. The investigation that started in 2014 in Connecticut dug deep into phone records, emails and thousands of documents between these pharmaceutical companies which colluded and conspired to raise prices of every day generics needed by Americans. These companies perpetrated a multi-billion dollar fraud scheme. This lawsuit is separate and apart from a previous multidistrict litigation which alleged the fixing of generic medication prices.

Our office is currently looking into the complaint filed and will be assigning it to one of our co-counsels to file for recovery in the near future.

Related Posts